Index concentration and valuation risks are back in US equities Index concentration and valuation risks are back in US equities Index concentration and valuation risks are back in US equities

Index concentration and valuation risks are back in US equities

PG
Peter Garnry

Head of Equity Strategy

Summary:  Concentration and valuation risks are coming back into US equities as May 2023 is ending today. The rally this year has been predominately driven by technology stocks and especially recently AI-related stocks. The narrowness of the rally and the fact that US equity valuations are back to levels not seen since July 2022 are elevating risks for investors and lowering future expected returns.


Key points in this equity note:

  • US equities have rallied this year on the back of exuberance in a narrow group of technology stocks and top 10 stocks in the S&P 500.

  • Concentration and valuation risks are reaching alarming levels, but could get worse if the AI hyped rally continues.

  • Equity valuations in the US are back to levels not seen since July 2022 and the current equity valuation suggests 10-year annualised real rate returns of -3% to +3% significantly below the long-term average of +5%

Concentration risks are never a good sign for the market

The total return in S&P 500 this year is 10.3% as of yesterday’s close, but the rally has been extremely unbalanced as we have written extensively about in this year’s equity notes. Just look at the best performing stocks this year. Starting with Apple as the biggest stock in S&P 500 with a market value of $2.79trn at the bottom of the performance table and moving upwards see total returns year-to-date of 37% or higher indicating the wild performance of not only technology companies but especially the largest stocks in the index such as Nvidia, Meta, Tesla, Amazon, Alphabet, Microsoft, and Apple. Concentration risk and narrow rallies in equities are often not good signs as they reflect a narrow theme played by the market and thus things can quickly turn around if the theme is sold off again. One potential catalyst could be a weaker than estimated US economy over the summer months.

Year-to-date returns | Source: Bloomberg

AI hype pushes US equity market back to dangerous equity valuation

The rally in US technology stocks this year, and in particular AI-related stocks, due to the market pricing in Fed rate cuts as the Fed will be forced to respond to lower economic growth, has pushed US equity market valuations to the highest level since July 2022. As we wrote in yesterday’s equity note, the global semiconductor industry has reached the highest equity valuations since early 2010 as growth expectations for semiconductors due to trends such as AI, electric vehicles and data center have fever levels. It almost feels like an echo from past bubbles.

Our combined equity valuation index on US equities reached 0.82 standard deviations above the historical average since 1992 up from 0.21 in September 2022. In other words, the US equity market never repriced below its long-term average underscoring the strong sentiment in US equities. If we look at what the current equity valuation means for future returns, based on past patterns, then we can see that the expected 10-year annualised real rate return is between -3% to +3% suggesting significant downside risks relative to the long-term average of +5% real rate return. Lofty equity valuations often goes hand in hand with overextended equity valuations in growth pockets of the market leading to subsequent outperformance of value stocks, which AQR co-founder Cliff Asness also recently predicted at the Morningstar Investment Conference.

Nvidia share price | Source: Bloomberg
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged foreign exchange trading); Type 4 Regulated Activity (Advising on securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.